Presentation TCT 2017 Putting the Evidence Together: Updating Guidelines, Patient Selection, and Insurance Coverage I - Neurology Perspective Presenter: Robert J. Sommer, David L. Tirschwell November 01, 2017
Presentation TCT 2017 Pivotal PFO Stroke Trial Update I: REDUCE Presenter: Robert J. Sommer, David L. Tirschwell, John F. Rhodes November 01, 2017
Presentation TCT 2017 Pivotal PFO Stroke Trial Update II: CLOSE Presenter: Robert J. Sommer, David L. Tirschwell, Guillaume Turc November 01, 2017
Presentation TCT 2017 Pivotal PFO Stroke Trial Update I: RESPECT Presenter: Robert J. Sommer, David L. Tirschwell November 01, 2017
Presentation TCT 2017 Percutaneous Suture-mediated Patent Foramen Ovale (PFO) Closure: Early Results With NobleStitchEL Device Presenter: Daniel Burkhoff, Samir R. Kapadia, Achille Gaspardone November 01, 2017
News Conference News TCT 2017 Novel Percutaneous Suture-Based Solution for PFO Closure Shows Promise Yael L. Maxwell October 31, 2017
News Conference News TCT 2017 3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike Yael L. Maxwell October 31, 2017
Presentation TCT 2017 Transcatheter Closure of a Sinus Venosus ASD With Partial Anomalous Pulmonary Venous Connection Presenter: Vasilis Babaliaros, Shmuel Banai, John P. Breinholt October 30, 2017
Presentation TCT 2017 PFO Closure in Cryptogenic Stroke Presenter: David Hildick-Smith, Lars Sondergaard October 29, 2017
Presentation TCT 2016 Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do? Presenter: Eustaquio Maria Onorato, Richard Smalling, Robert J. Sommer November 01, 2016
Presentation TCT 2016 The REDUCE Trial: Will It Be Positive and What Will We Learn? Presenter: Eustaquio Maria Onorato, Richard Smalling, John F. Rhodes November 01, 2016
Presentation TCT 2016 What Should Be the Next Series of Clinical Trials in PFO Closure? Presenter: Eustaquio Maria Onorato, Richard Smalling, John D. Carroll November 01, 2016
Presentation TCT 2016 The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed? Presenter: Eustaquio Maria Onorato, Richard Smalling, David E. Thaler November 01, 2016
Presentation TCT 2016 Anticipating FDA approval of the Amplatzer PFO Occluder: Indications, Rational Dispersion of Technology, and Post-Approval Studies Presenter: Eustaquio Maria Onorato, Richard Smalling November 01, 2016
Presentation TCT 2016 Building a Successful PFO Closure Program Presenter: John D. Carroll, Christian Spies November 01, 2016
Presentation TCT 2016 Available Devices/Techniques for Closure of PFO Presenter: John D. Carroll, Christian Spies, Michael J. Mullen November 01, 2016
Presentation TCT 2016 The RoPE Score: How to select pathologic PFO? Presenter: John D. Carroll, Christian Spies, David E. Thaler November 01, 2016
Presentation TCT 2016 What Do the Randomized Clinical Trials Tell Us and How Did the FDA Respond? Presenter: John D. Carroll, Christian Spies November 01, 2016
Presentation TCT 2016 Long-term Outcomes of Coarctation Stenting Presenter: John D. Carroll, Thomas J Forbes November 01, 2016
Presentation TCT 2016 Balloon Angioplasty Vs Bare Metal Vs Stents Covered Stents: How Do You Make the Decision? Presenter: John D. Carroll, Thomas J Forbes, Elchanan Bruckheimer November 01, 2016